Abiopharma

🔍 Mazarakis John (Executive)

Company: Chicago Atlantic Real Estate Finance, Inc. (REFI)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 40,181 shares of Common Stock at $10.6666 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: false | shares_owned_after: 519,032.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 7,530 shares of Common Stock at $10.67 per share (Direct)
  Date: 2026-08-27 | Code: P | equity_swap_involved: false | shares_owned_after: 526,562.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: Spouse | shares_owned_after: 5,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: Held through ownership of interests in Joppa Seasoning, LLC | shares_owned_after: 31,524.00 | Footnotes: F2

Footnotes:

• F1: The price reported reflects the weighted-average purchase price from several discrete transactions executed throughout the Transaction Date at prices that ranged from $10.65 to $10.67 per share. Upon request, the Reporting Person has agreed to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission full information regarding the number of shares purchased at each price within the range set forth in this footnote.
• F2: The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.